XF 73
XF 73 is a novel antimicrobial agent being developed by Destiny Pharma. It is a member of the class of drugs known as cationic peptides, which are designed to kill bacteria by disrupting their cell membranes. XF 73 is being developed for the prevention of post-surgical staphylococcal infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA).
Mechanism of Action[edit | edit source]
XF 73 works by disrupting the bacterial cell membrane, leading to cell death. Unlike many other antimicrobial agents, XF 73 does not target specific proteins or enzymes within the bacterial cell, which means that bacteria are less likely to develop resistance to it.
Clinical Development[edit | edit source]
XF 73 is currently in clinical trials for the prevention of post-surgical staphylococcal infections. In preclinical studies, XF 73 has shown potent activity against a range of Gram-positive bacteria, including MRSA.
Potential Advantages[edit | edit source]
XF 73 has several potential advantages over existing antimicrobial agents. Firstly, its unique mechanism of action means that it is less likely to lead to the development of antimicrobial resistance. Secondly, it has a rapid bactericidal activity, killing bacteria within minutes of contact. Finally, it has shown activity against bacteria in biofilms, which are often resistant to other antimicrobial agents.
Potential Disadvantages[edit | edit source]
As with any new drug, there are potential disadvantages to XF 73. These include the possibility of side effects, the potential for drug interactions, and the need for further research to fully understand its efficacy and safety profile.
See Also[edit | edit source]
- Antimicrobial resistance
- Cationic peptides
- Clinical trials
- Methicillin-resistant Staphylococcus aureus
- Staphylococcal infections
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
